|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/00 |
| (11) | Patento numeris | 2173378 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08779855.9 |
| Europos patento paraiškos padavimo data | 2008-06-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/008084 |
| Data | 2008-06-27 |
| (87) | Numeris | WO 2009/002562 |
| Data | 2008-12-31 |
| (30) | Numeris | Data | Šalis |
| 937471 P | 2007-06-27 | US |
| (72) |
PAVLAKIS, George, N., US
VOURNAKIS, John, N., US
FELBER, Barbara, K., US
FINKIELSZTEIN, Sergio, US
|
| (73) |
Admune Therapeutics LLC,
107 Water Street, Danvers, MA 01923,
US
The United States Of America,As Represented By The Secretary, Department Of Health And Human Services, Office Of Technology Transfer National Institute Of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US |
| (54) | COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF |
| COMPLEXES OF IL-15 AND IL-15RALPHA AND USES THEREOF |